Browsing Tag
Breast Cancer
62 posts
BCAL Diagnostics (ASX: BDX) shares rise after ClearNote deal — is this the turning point investors were waiting for?
BCAL Diagnostics (ASX: BDX) expands with ClearNote Health deal for ovarian and pancreatic cancer tests—can this pivot revive its struggling stock?
September 18, 2025
Lilly’s Verzenio hits overall survival milestone in early breast cancer after 2-year treatment
Verzenio improves survival in high-risk early breast cancer, confirms Eli Lilly. Find out how this changes the treatment landscape.
August 31, 2025
PROTAC vs SERD: Is protein degradation the future of endocrine resistance treatment?
Vepdegestrant challenges oral SERDs with PROTAC innovation. Explore trial results, safety, and the future of protein degradation in breast cancer care.
June 9, 2025
Vepdegestrant delivers Phase 3 success for Arvinas and Pfizer in ESR1-mutant breast cancer
Vepdegestrant shows 43% risk reduction in ESR1-mutant breast cancer vs fulvestrant. Learn how Arvinas and Pfizer aim for FDA filing in H2 2025.
June 7, 2025
Understanding Breast Cancer: Causes, symptoms, diagnosis, and advancements in treatment
Breast cancer is a malignant disease that develops when abnormal cells in the breast tissue grow uncontrollably, often…
January 26, 2025
Immutep completes patient enrolment for Phase II trial of eftilagimod alpha in metastatic breast cancer
Immutep Limited, a clinical-stage biotechnology company specializing in advanced LAG-3 immunotherapies, has announced the completion of patient enrolment…
October 6, 2024
Sermonix Pharmaceuticals awarded U.S. patent for lasofoxifene in breast cancer treatment
Sermonix Pharmaceuticals Inc., a leader in biopharmaceutical innovations, has achieved a significant milestone with the issuance of a…
July 20, 2024
G1 Therapeutics’ Phase 3 trial of trilaciclib for metastatic triple negative breast cancer continues as planned
In a significant update for the oncology community, G1 Therapeutics, Inc. (Nasdaq: GTHX), a commercial-stage company specializing in…
February 13, 2024
Zydus Lifesciences gains FDA approval for Cyclophosphamide Capsules
Zydus Lifesciences Limited, a leading pharmaceutical company, has achieved a significant milestone by receiving final approval from the…
December 17, 2023
Menarini’s EMERALD study of ORSERDU in breast cancer shows promising results
The Menarini Group and its subsidiary, Stemline Therapeutics, Inc., have made a significant stride in breast cancer treatment…
December 9, 2023